TIDMGSK

RNS Number : 1439A

GlaxoSmithKline PLC

24 May 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Ms D Conrad 
===  ========================  ============================================ 
 b)   Position/status          SVP, Human Resources 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            The exercise of options over 12,650 Ordinary 
       transaction              Shares, granted on 22 February 2010 under 
                                the GlaxoSmithKline Share Option Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP12.035    12,650 
                                              ---------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume        n/a (single transaction) 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-05-23 
===  ========================  ============================================ 
 f)   Place of the             n/a 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Ms D Conrad 
===  ========================  ============================================== 
 b)   Position/status          SVP, Human Resources 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================== 
 b)   Nature of the            The sale of 12,650 Ordinary Shares, granted 
       transaction              on 22 February 2010 under the GlaxoSmithKline 
                                Share Option Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.892    12,650 
                                              ---------- 
===  ========================  ============================================== 
 d)   Aggregated information 
       Aggregated volume        n/a (single transaction) 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-05-23 
===  ========================  ============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHKZLBLKEFEBBB

(END) Dow Jones Newswires

May 24, 2019 05:54 ET (09:54 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.